Health care effects and medical benefits of a smartphone-based diabetes self-management application : study protocol for a randomized controlled trial
Ehrmann, Dominic; Eichinger, V.; Vesper, Iris; u. a. (2023): Health care effects and medical benefits of a smartphone-based diabetes self-management application : study protocol for a randomized controlled trial, in: Bamberg: Otto-Friedrich-Universität, S. 1–8.
Details
- Fakultät/Lehrstuhl
- Autorin(nen)/Autor(en)
Ehrmann, Dominic; Eichinger, V.; Vesper, Iris; Kober, J.; Kraus, M.; Schäfer, V.;
Hermanns, Norbert; Kulzer, Bernhard; Silbermann, Stephan
- Verlagsangabe
- Otto-Friedrich-Universität : Bamberg
- Erscheinungsjahr
- 2023
- Quelle/Weitere Ausgabe
- Trials, 23 (2022), 1, 282. - ISSN: 1745-6215
- Jahr der Erstpublikation
- 2022
- Sprache(n)
- Englisch
- Lizenz
- URN
- Abstract
Background:
Diabetes self-management is a mainstay of diabetes care, but the implementation of self-management regimens into daily life is complex and often results in discouragement and distress. Modern approaches such as smartphone-based self-management applications are therefore needed to support people with diabetes. Since reimbursability would increase the availability of such digital applications to people with diabetes, we designed a study that meets all scientific and methodological requirements set by the German Digital Healthcare Act to allow reimbursement for a specific application (mySugr PRO). Here, we report the protocol of this study that aims at evaluating the efficacy of the digital self-management application with regard to patient-reported outcomes and medical benefits.
Methods/design:
This multicenter, open-label, randomized, parallel-group, controlled trial will evaluate the health care effects and medical benefits of mySugr PRO. A total of 466 people with diabetes will be randomly allocated (2:1 randomization) to the interventional group (n = 311) that will use the digital self-management application during the 12-week study period or the control group (n = 155; no usage of the application). Baseline and follow-up examinations will assess diabetes distress as the primary endpoint as well as empowerment, HbA1c, blood glucose data, self-management, general well-being, and treatment satisfaction as secondary endpoints. Statistical analyses will use an intention-to-treat procedure (using multiple imputation for missing values) as well as a per-protocol approach for sensitivity analysis.
Discussion:
To the best of our knowledge, this study will be one of the largest diabetes-specific evaluations of a digital health application supporting people with diabetes in their diabetes self-management that follow the requirements of the German Digital Healthcare Act.
Trial registration:
German Clinical Trial Register DRKS00022923. Registered on 22 October 2020.
- GND-Schlagwort(e)
- Diabetes mellitusSelbstmanagementtherapieE-Health
- Freie Schlagwort(e)
- DiabetesSelf-managementDiabetes distressDigital health application
- DDC-Klassifikation
- 150 Psychologie
- RVK-Klassifikation
- YC 7200
- Peer Reviewed
- ja
- Internationale Verbreitung
- ja
- Open-Access-Zeitschrift
- ja
- Dokumenttyp
- Artikel in einer Zeitschrift / Postprint
- URI
- Datum der Freischaltung
- 11.10.2023